# Filing Detail

Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-099629
Filing Date
2025-07-29
Accepted
2025-07-29 16:09:29
Documents
17
Effectiveness Date
2025-07-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-8 | alks-20250729.htm | S-8 | 150014
2 | EX-5.1 | alks-ex5_1.htm | EX-5.1 | 105178
3 | EX-23.1 | alks-ex23_1.htm | EX-23.1 | 3113
4 | EX-FILING FEES | alks-exfiling_fees.htm iXBRL | EX-FILING FEES | 12862
5 | GRAPHIC | img139586189_0.jpg | GRAPHIC | 109157
6 | GRAPHIC | img139586189_1.jpg | GRAPHIC | 399520
7 | GRAPHIC | img139586189_2.jpg | GRAPHIC | 22461
| Complete submission text file | 0000950170-25-099629.txt |  | 1120470

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
19 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-exfiling_fees_htm.xml | XML | 4874

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289037 | Film No.: 251161929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)